Transcat Inc. filings document material events for a calibration services and test-instrument distribution company. Recent Form 8-K reports cover quarterly results furnished under Item 2.02, earnings press releases and presentation exhibits, and Regulation FD disclosures tied to operating updates.
The company’s filings also record governance and equity-compensation matters, including executive appointments, officer transitions, retention equity awards, and transition agreements. Acquisition-related 8-K disclosures describe completed purchases of calibration laboratory businesses, related material agreements, consideration, exhibits, and customary representations, warranties and holdback provisions.
Transcat, Inc. reported an equity award for senior management. Sr. VP of Human Resources Theresa A. Conroy received 10,380 restricted stock units (RSUs) on January 6, 2026, which convert into common stock on a one-for-one basis and, under the 2021 Stock Incentive Plan, generally vest on January 6, 2028. The filing also lists previously granted RSUs totaling 1,098, 783, and 2,024 units that vest on March 25, 2028, March 27, 2027, and March 28, 2026, respectively. In addition, Conroy holds a fully exercisable stock option for 2,000 shares at an exercise price of $63.17 per share and directly owns 836 shares of Transcat common stock.
Transcat Inc reported an equity award for its Sr. VP Finance & CFO, Thomas L. Barbato. On January 6, 2026, he received 19,772 restricted stock units (RSUs), which convert into common stock on a one-for-one basis and, under the 2021 Stock Incentive Plan, are scheduled to vest on January 6, 2028, subject to the award notice.
After this grant, he directly holds these 19,772 RSUs plus additional RSU holdings of 2,691, 1,919, and 3,686 units with vesting dates in 2026–2028. He also holds stock options for 6,000 shares at $90.92 per share expiring on January 3, 2027 and 5,000 shares at $63.17 per share expiring on May 25, 2027, both reported as directly owned. In addition, he directly owns 1,699 shares of Transcat common stock.
Transcat, Inc. disclosed that its Compensation Committee approved a special one-time equity retention package for four executive officers under the 2021 Stock Incentive Plan. The awards are in the form of restricted stock units, with grants of 19,772 RSUs to Thomas L. Barbato, 10,380 to Theresa A. Conroy, 5,190 to Michael J. Haddad, and 12,028 to Michael W. West.
The retention awards are scheduled to vest on January 6, 2028, conditioned on each executive’s continued employment and as otherwise detailed in the award agreements. The company explains that these awards are intended to preserve leadership continuity during the transition to a successor chief executive officer and to directly incentivize the executives’ ongoing contributions.
Transcat, Inc. reported Q2 FY2026 results with total revenue of $82.3 million, up 21.3% year over year. Service revenue was $52.8 million and Distribution revenue was $29.4 million. Gross profit rose to $26.8 million with a total gross margin of 32.5%.
Operating income was $3.5 million as operating expenses increased with acquisitions and higher compensation. Net income was $1.3 million and diluted EPS was $0.14. Interest and other expense increased to $1.5 million, reflecting higher borrowings.
For the first six months, revenue reached $158.7 million and net income was $4.5 million. Operating cash flow was $16.5 million, while investing cash flow used $91.6 million, primarily for acquisitions. The company closed a new five‑year $150.0 million secured revolving credit facility; $111.9 million was outstanding as of September 27, 2025. Transcat acquired Essco for approximately $85.6 million and earlier acquired Martin for approximately $81.8 million. Total assets were $484.9 million, long‑term debt was $111.9 million, and shares outstanding were 9,328,412 as of October 31, 2025.
Transcat, Inc. (TRNS) announced fiscal 2026 second‑quarter results for the period ended September 27, 2025, via a press release furnished as Exhibit 99.1. The company also posted investor presentation slides (Exhibit 99.2) on its website to accompany an earnings conference call and webcast scheduled for 4:30 p.m. Eastern Time on November 3, 2025.
The materials are furnished under Item 2.02 and are not deemed filed under the Securities Exchange Act of 1934.
Robert Mecca, a director of Transcat Inc. (TRNS), reported equity award activity on 09/10/2025 and 09/11/2025. On 09/10/2025 the filing shows restricted stock units (RSUs) granted totaling 1,587 RSUs that convert one-for-one into common stock and, per the award terms, generally vest on September 10, 2026. On 09/11/2025 a separate tranche of 704 RSUs is reported as vested, converting into common stock. The filing also discloses a stock option covering 10,000 shares with an exercise price of $98.88 and an expiration date of January 24, 2034; this option vests pro rata over five years. The form is signed by an attorney-in-fact on behalf of Mr. Mecca on September 11, 2025. The disclosure is limited to these award and vesting events and does not include earnings, cash transactions, or other operational details.
Transcat Inc. (TRNS) director Mbago M. Kaniki received equity awards and holds an option position. The filing reports conversion-eligible restricted stock units (RSUs) that convert one-for-one into common stock. RSUs granted 09/10/2025 total 1,587 shares and vest on 09/10/2026. An additional 704 RSUs vested and converted on 09/11/2025, increasing beneficial ownership by 704 shares. The reporting person also holds a stock option to buy 10,000 shares at $47.14 per share exercisable on a pro rata vesting schedule through 05/12/2031. After the reported transactions, the filer directly beneficially owns 2,593 shares.
Gary J. Haseley, a director of Transcat Inc. (TRNS), reported equity changes arising from restricted stock unit (RSU) activity in September 2025. On September 11, 2025 704 shares were acquired following RSU vesting at no cash cost. Following that transaction, Mr. Haseley held 39,102 shares directly. The filing also shows 1,200 shares held indirectly through family trusts.
Separately, on September 10, 2025 he received an award of 1,587 RSUs granted under a Rule 16b-3 exempt transaction; those RSUs vest on September 10, 2026 and convert one-for-one to common stock when vested. The filing is a routine Section 16 disclosure documenting vesting and a new RSU grant.
Christopher P. Gillette, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership on Form 4. The filing shows 704 shares were acquired on 09/11/2025 through the vesting of restricted stock units (RSUs) and are reported with a $0 per-share conversion value. The document also discloses an earlier RSU grant of 1,587 RSUs dated 09/10/2025 that convert one-for-one to common stock and generally vest on 09/10/2026. In addition, Mr. Gillette holds a stock option covering 10,000 shares with an exercise price of $109.55 and pro rata vesting over five years. The filing was signed by an attorney-in-fact on behalf of Mr. Gillette on 09/11/2025.
Reporting person: Dawn DePerrior, a director of Transcat, Inc. (TRNS). The Form 4 discloses equity awards and option activity reported for transactions on September 10-11, 2025. On 09/10/2025 Ms. DePerrior was awarded 1,587 restricted stock units (RSUs) that convert one-for-one into common shares and vest on 09/10/2026. On 09/11/2025 704 RSUs vested and converted into 704 shares of common stock, increasing her beneficial ownership by that amount. Also reported is a stock option to purchase 10,000 shares at an exercise price of $92.92 that vests pro rata over five years from the grant date and expires 10/26/2033. All reported holdings are direct.